Sale!

CLCN7 Gene Osteopetrosis Autosomal Dominant Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLCN7 Gene Osteopetrosis Autosomal Dominant Type 1 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the CLCN7 gene, which are known to cause Autosomal Dominant Osteopetrosis Type 1 (ADO1). This condition is characterized by an increased bone density and abnormal bone growth, leading to a variety of health issues including bone fragility, neurological complications, and impaired function of bone marrow. The test is crucial for early diagnosis and management of the condition, allowing for better prognosis and targeted treatments.

Conducted at DNA Labs UAE, this genetic test involves analyzing the patient’s DNA to identify any mutations in the CLCN7 gene that are indicative of ADO1. The process is comprehensive, ensuring high accuracy and reliability in the results. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to perform this intricate analysis.

By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and manage the condition more effectively. DNA Labs UAE offers state-of-the-art facilities and a team of genetic experts to guide patients through the testing process, ensuring a seamless and informative experience.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLCN7 Gene Osteopetrosis autosomal dominant type 1 Genetic Test

At DNA Labs UAE, we offer the CLCN7 Gene Osteopetrosis autosomal dominant type 1 Genetic Test at a cost of AED 4400.0. This test is designed to diagnose osteopetrosis, autosomal dominant type 1 by analyzing the CLCN7 gene for any mutations or variations.

Test Details

The CLCN7 gene is associated with osteopetrosis, autosomal dominant type 1, a rare genetic disorder characterized by abnormal bone growth and density. Individuals with this condition have an increased susceptibility to fractures and other skeletal abnormalities.

Our NGS (Next-Generation Sequencing) technology allows for the simultaneous analysis of multiple genes, including the CLCN7 gene. By identifying mutations or variations in the CLCN7 gene, this test can provide valuable information about the specific genetic variant causing osteopetrosis, autosomal dominant type 1.

Test Components and Price

The CLCN7 Gene Osteopetrosis autosomal dominant type 1 Genetic Test is priced at AED 4400.0. The sample condition required for this test can be either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The report for this genetic test will be delivered within 3 to 4 weeks.

Test Method

We utilize NGS technology for the CLCN7 Gene Osteopetrosis autosomal dominant type 1 Genetic Test.

Test Type and Doctor

This test falls under the category of Osteology Dermatology Immunology Disorders and is performed by a Dermatologist.

Test Department

This test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the CLCN7 Gene Osteopetrosis autosomal dominant type 1 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CLCN7 Gene Osteopetrosis, autosomal dominant type 1.

Importance of Genetic Testing for Osteopetrosis, autosomal dominant type 1

Genetic testing for osteopetrosis, autosomal dominant type 1 should be performed by a qualified healthcare professional or genetic counselor. The results of the test can help diagnose the condition and provide valuable information about the specific genetic variant causing it. This information is crucial for determining appropriate treatment and management strategies for affected individuals and their families.

Test Name CLCN7 Gene Osteopetrosis autosomal dominant type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLCN7 Gene Osteopetrosis, autosomal dominant type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCN7 Gene Osteopetrosis, autosomal dominant type 1 NGS Genetic DNA Test gene CLCN7
Test Details

The CLCN7 gene is associated with a condition called osteopetrosis, autosomal dominant type 1. Osteopetrosis is a rare genetic disorder characterized by abnormal bone growth and density, leading to increased susceptibility to fractures and other skeletal abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the case of osteopetrosis, an NGS genetic test can analyze the CLCN7 gene to identify any mutations or variations that may be present.

By identifying mutations in the CLCN7 gene, NGS genetic testing can help diagnose osteopetrosis, autosomal dominant type 1 and provide information about the specific genetic variant causing the condition. This information can be useful for determining the appropriate treatment and management strategies for affected individuals and their families.

It’s important to note that genetic testing for osteopetrosis, autosomal dominant type 1 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.